Heteroresistance to Fluconazol in Clinical and Environmental Brazilian Strains of Cryptococcus neoformans/C. gattii Species Complex

被引:3
|
作者
Feliciano L.M. [1 ]
Ramos S.D.P. [2 ]
Szeszs M.W. [2 ]
Martins M.A. [2 ]
Bonfietti L.X. [2 ]
Oliveira R.A. [2 ]
Santos D.C.S. [2 ]
Fadul L.H. [2 ]
Silva D.F. [2 ]
Paula C.R. [3 ]
Trilles L. [4 ]
Silva L.E.A. [5 ]
Ferreira-Paim K. [5 ]
Mora D.J. [5 ]
Andrade A.A. [5 ]
Silva P.R. [5 ]
Silva-Vergara M.L. [5 ]
Roberto T.N. [6 ]
Melhem M.S.C. [2 ]
机构
[1] Graduate Program of the Disease Control Coordination, Secretary of Health, São Paulo
[2] Mycology Department, Instituto Adolfo Lutz, Rio Claro, São Paulo
[3] São Paulo University, São Paulo
[4] Oswaldo Cruz Foundation, Evandro Chagas Clinical Research Institute, Rio de Janeiro
[5] Disciplina de Doenças Infecciosas Parasitárias, Universidade Federal do Triângulo Mineiro, Uberaba, Minas Gerais
[6] São Paulo Federal University, São Paulo
基金
巴西圣保罗研究基金会;
关键词
Antifungal resistance; Cryptococcus gattii; Cryptococcus neoformans; Fluconazole; Heteroresistance;
D O I
10.1007/s12281-017-0298-1
中图分类号
学科分类号
摘要
Purpose of Study: To review the literature on heteroresistance to fluconazole (FLC) and investigate the level of heteroresistance to FLC (LHF), we analyzed 100 clinical and environmental Brazilian Cryptococcus strains. Recent Findings: Heteroresistance is a phenomenon described as the emergence of resistant subpopulation cells within a single susceptible strain that can tolerate higher concentrations of fluconazole above the minimal inhibitory concentration (MIC) level. Summary: We found lower FLC-MICs (0.12–64 mg/L) than LHF (8–128 mg/L). Highly heteroresistant adapted subpopulations (256 mg/L) was found in minority (9%) strains, but importantly, 33% showed low FLC-MIC (8 mg/L). We concluded for similar LHF in both species, but higher LHF in clinical strains in comparison to environmental ones. Our findings stressed that the LHF is not correlated to species and pretty is strain-dependent and alert about high heteroresistant subpopulations that hardly reverts to the original LHF even upon the removal of drug pressure. © 2017, Springer Science+Business Media, LLC.
引用
收藏
页码:190 / 196
页数:6
相关论文
共 50 条
  • [31] Genetic diversity and antifungal susceptibilities of environmental Cryptococcus neoformans and Cryptococcus gattii species complexes
    Taha, Mohamed
    Tartor, Yasmine H.
    Abd Elaziz, Rana M.
    Elsohaby, Ibrahim
    IMA FUNGUS, 2024, 15 (01)
  • [32] Environmental Triazole Induces Cross-Resistance to Clinical Drugs and Affects Morphophysiology and Virulence of Cryptococcus gattii and C. neoformans
    Bastos, Rafael Wesley
    Silva Carneiro, Hellem Cristina
    Neves Oliveira, Lorena Vivien
    Rocha, Karen Maia
    Cota Freitas, Gustavo Jose
    Costa, Marliete Carvalho
    Ferreira Magalhaes, Thais Furtado
    Dutra Carvalho, Vanessa Silva
    Rocha, Claudia Emanuela
    Ferreira, Gabriella Freitas
    Paixao, Tatiane Alves
    Moyrand, Frederique
    Janbon, Guilhem
    Santos, Daniel Assis
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (01)
  • [33] Characterization by PCR-RFLP of the Cryptococcus neoformans and Cryptococcus gattii species complex in Venezuela
    Ferrara, Giuseppe
    Mercedes Panizo, Maria
    Urdaneta, Emilia
    Alarcon, Victor
    Garcia, Nataly
    Moreno, Xiomara
    Maria Capote, Ana
    Reviakina, Vera
    Dolande, Maribel
    INVESTIGACION CLINICA, 2018, 59 (01): : 28 - 40
  • [34] Characterization of clinical isolates of the Cryptococcus neoformans-Cryptococcus gattii species complex from the Amazonas State in Brazil
    Da Silva, Babbyngttonn Khell
    Freire, Ana Karla
    Bentes, Amaury Dos Santos
    Sampaio, Ivanete De Lima
    Santos, Lucilaide Oliveira
    Dos Santos, Mirlane Silva
    De Souza, Joao Vicente
    REVISTA IBEROAMERICANA DE MICOLOGIA, 2012, 29 (01): : 40 - 43
  • [35] Molecular epidemiological and phylodynamic analyses of Cryptococcus neoformans -Cryptococcus gattii species complex in Taiwan
    Tseng, H. K.
    Cho, W. L.
    Liu, C. P.
    Chen, Y. C.
    MYCOSES, 2014, 57 : 40 - 40
  • [36] Molecular typing of environmental Cryptococcus neoformans/C-gattii species complex isolates from Manaus, Amazonas, Brazil
    Barbosa Alves, Gleica Soyan
    Lima Freire, Ana Karla
    Bentes, Amaury dos Santos
    de Souza Pinheiro, Jose Felipe
    Braga de Souza, Joao Vicente
    Wanke, Bodo
    Matsuura, Takeshi
    Jackisch-Matsuura, Ani Beatriz
    MYCOSES, 2016, 59 (08) : 509 - 515
  • [37] Endophytic fungal compounds active against Cryptococcus neoformans and C. gattii
    Pereira, Cristiane B.
    de Oliveira, Djalma M.
    Hughes, Alice F. S.
    Kohlhoff, Markus
    Vieira, Mariana L. A.
    Martins Vaz, Aline B.
    Ferreira, Mariana C.
    Carvalho, Camila R.
    Rosa, Luiz H.
    Rosa, Carlos A.
    Alves, Tania M. A.
    Zani, Carlos L.
    Johann, Susana
    Cota, Betania B.
    JOURNAL OF ANTIBIOTICS, 2015, 68 (07): : 436 - 444
  • [38] Endophytic fungal compounds active against Cryptococcus neoformans and C. gattii
    Cristiane B Pereira
    Djalma M de Oliveira
    Alice FS Hughes
    Markus Kohlhoff
    Mariana LA Vieira
    Aline B Martins Vaz
    Mariana C Ferreira
    Camila R Carvalho
    Luiz H Rosa
    Carlos A Rosa
    Tânia MA Alves
    Carlos L Zani
    Susana Johann
    Betania B Cota
    The Journal of Antibiotics, 2015, 68 : 436 - 444
  • [39] Mortality due to Cryptococcus neoformans and C. gattii in Mozambique: an Autopsy Study
    Rakislova, Natalia
    Castillo, Paola
    Carrilho, Carla
    Menendez, Clara
    Hurtado, Juan
    Letang, Emili
    Bassat, Quique
    Ordi, Jaime
    Ismail, Mamudo R.
    Fernandes, Fabiola
    Martinez, Miguel J.
    LABORATORY INVESTIGATION, 2018, 98 : 12 - 12
  • [40] Antifungal susceptibility of Cryptococcus neoformans/gattii spp complex; Comparison between clinical and environmental isolates
    Siddaiah, Nagarathn
    Mukyopadhay, S. Lahiri
    Bahubali, Veena. H.
    Manjunath, Netravath
    Maji, Sayani
    MEDICAL MYCOLOGY, 2018, 56 : S38 - S38